A team of paleoanthropologists and geneticists from Aix Marseille Univ, CNRS, EFS, ADES has found evidence of what may have ...

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

Every two minutes, a man is diagnosed with prostate cancer in our country. This disease is currently the second-leading cancer-related killer of men in the United States.

You might be given one or more of these blood parts based on your needs. When you have a blood transfusion, it’s important to be given blood that is compatible with (matches) your blood. Blood comes ...

Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early ...

Biopharmaceutical company Ocugen, Inc. (NASDAQ: OCGN) has announced that the U.S. Food and Drug Administration (FDA) has ...

I will be voting against your nomination because your views are dangerous to our state and to our country,” the Maryland Democrat said before yielding her time.

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

A recent study has uncovered key insights into the differing tumour rejection behaviours of chimeric antigen receptor T cells ...

Federal Communications Commission Chair Brendan Carr announced he would be investigating two publicly funded media outlets.

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...

Assays for hepatitis B surface antigen (HBsAg) are the most frequently ... dialysis patients who were receiving HBsAg testing as part of routine and ongoing monitoring. Beyond 14 days, there ...